121 related articles for article (PubMed ID: 25198242)
21. The burden and measurement of cardiovascular disease in SSc.
Mok MY; Lau CS
Nat Rev Rheumatol; 2010 Jul; 6(7):430-4. PubMed ID: 20517296
[TBL] [Abstract][Full Text] [Related]
22. Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: potential utility of immunosuppressive therapy in cardiac damage progression.
Pieroni M; De Santis M; Zizzo G; Bosello S; Smaldone C; Campioni M; De Luca G; Laria A; Meduri A; Bellocci F; Bonomo L; Crea F; Ferraccioli G
Semin Arthritis Rheum; 2014 Feb; 43(4):526-35. PubMed ID: 23932313
[TBL] [Abstract][Full Text] [Related]
23. 'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus.
Bruce IN
Rheumatology (Oxford); 2005 Dec; 44(12):1492-502. PubMed ID: 16234277
[TBL] [Abstract][Full Text] [Related]
24. From vulnerable plaque to vulnerable patient--Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report.
Naghavi M; Falk E; Hecht HS; Jamieson MJ; Kaul S; Berman D; Fayad Z; Budoff MJ; Rumberger J; Naqvi TZ; Shaw LJ; Faergeman O; Cohn J; Bahr R; Koenig W; Demirovic J; Arking D; Herrera VL; Badimon J; Goldstein JA; Rudy Y; Airaksinen J; Schwartz RS; Riley WA; Mendes RA; Douglas P; Shah PK;
Am J Cardiol; 2006 Jul; 98(2A):2H-15H. PubMed ID: 16843744
[TBL] [Abstract][Full Text] [Related]
25. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement.
Lopez LR; Simpson DF; Hurley BL; Matsuura E
Ann N Y Acad Sci; 2005 Jun; 1051():313-22. PubMed ID: 16126973
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients.
Zhang CY; Lu LJ; Li FH; Li HL; Gu YY; Chen SL; Bao CD
J Clin Rheumatol; 2009 Apr; 15(3):111-6. PubMed ID: 19300290
[TBL] [Abstract][Full Text] [Related]
27. Accelerated atherosclerosis in systemic lupus erythematosus and other connective tissue diseases.
Bartoloni Bocci E; Luccioli F; Angrisani C; Moscatelli S; Alunno A; Gerli R
Expert Rev Clin Immunol; 2007 Jul; 3(4):531-41. PubMed ID: 20477158
[TBL] [Abstract][Full Text] [Related]
28. Anti-lipoprotein lipase antibody in systemic sclerosis: association with elevated serum triglyceride concentrations.
Kodera M; Hayakawa I; Komura K; Yanaba K; Hasegawa M; Takehara K; Sato S
J Rheumatol; 2005 Apr; 32(4):629-36. PubMed ID: 15801017
[TBL] [Abstract][Full Text] [Related]
29. Micro- and macrovascular treatment targets in scleroderma heart disease.
Dimitroulas T; Giannakoulas G; Karvounis H; Garyfallos A; Settas L; Kitas GD
Curr Pharm Des; 2014; 20(4):536-44. PubMed ID: 23565639
[TBL] [Abstract][Full Text] [Related]
30. Early assessment of sub-clinical cardiac involvement in systemic sclerosis (SSc) using delayed enhancement cardiac magnetic resonance (CE-MRI).
Di Cesare E; Battisti S; Di Sibio A; Cipriani P; Giacomelli R; Liakouli V; Ruscitti P; Masciocchi C
Eur J Radiol; 2013 Jun; 82(6):e268-73. PubMed ID: 23510727
[TBL] [Abstract][Full Text] [Related]
31. Radial augmentation index is a surrogate marker of atherosclerotic burden in a primary prevention cohort.
Rosenbaum D; Giral P; Chapman J; Rached FH; Kahn JF; Bruckert E; Girerd X
Atherosclerosis; 2013 Dec; 231(2):436-41. PubMed ID: 24267263
[TBL] [Abstract][Full Text] [Related]
32. Systemic sclerosis and risk of cardiovascular disease: A PRISMA-compliant systemic review and meta-analysis of cohort studies.
Cen X; Feng S; Wei S; Yan L; Sun L
Medicine (Baltimore); 2020 Nov; 99(47):e23009. PubMed ID: 33217802
[TBL] [Abstract][Full Text] [Related]
33. Determinants of morbidity and mortality of systemic sclerosis in Canada.
Al-Dhaher FF; Pope JE; Ouimet JM
Semin Arthritis Rheum; 2010 Feb; 39(4):269-77. PubMed ID: 18706680
[TBL] [Abstract][Full Text] [Related]
34. Macrovascular disease in systemic sclerosis: the tip of an iceberg?
Belch JJ; McSwiggan S; Lau C
Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v16-7. PubMed ID: 18784129
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of coronary heart disease and cardiovascular risk factors in a national cross-sectional cohort study of systemic sclerosis.
Ngian GS; Sahhar J; Proudman SM; Stevens W; Wicks IP; Van Doornum S
Ann Rheum Dis; 2012 Dec; 71(12):1980-3. PubMed ID: 22532628
[TBL] [Abstract][Full Text] [Related]
36. Cardiovascular disease in systemic sclerosis.
Cannarile F; Valentini V; Mirabelli G; Alunno A; Terenzi R; Luccioli F; Gerli R; Bartoloni E
Ann Transl Med; 2015 Jan; 3(1):8. PubMed ID: 25705640
[TBL] [Abstract][Full Text] [Related]
37. Patients with scleroderma may have increased risk of osteoporosis. A comparison to rheumatoid arthritis and noninflammatory musculoskeletal conditions.
Yuen SY; Rochwerg B; Ouimet J; Pope JE
J Rheumatol; 2008 Jun; 35(6):1073-8. PubMed ID: 18412305
[TBL] [Abstract][Full Text] [Related]
38. Comparative assessment of vascular function in autoimmune rheumatic diseases: considerations of prevention and treatment.
Soltész P; Kerekes G; Dér H; Szücs G; Szántó S; Kiss E; Bodolay E; Zeher M; Timár O; Szodoray P; Szegedi G; Szekanecz Z
Autoimmun Rev; 2011 May; 10(7):416-25. PubMed ID: 21281743
[TBL] [Abstract][Full Text] [Related]
39. [Cardiopathy in systemic sclerosis].
Valentini G; Maione S
Recenti Prog Med; 1996 Nov; 87(11):557-63. PubMed ID: 9122540
[TBL] [Abstract][Full Text] [Related]
40. Autonomic and sensorimotor neuropathy in patients with systemic lupus erythematosus and systemic sclerosis.
Straub RH; Zeuner M; Lock G; Rath H; Hein R; Schölmerich J; Lang B
J Rheumatol; 1996 Jan; 23(1):87-92. PubMed ID: 8838514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
